January 19, 2018: The Los Angeles County Coroner released the results of the toxicology analysis for Tom Petty. His death has now been ruled an accidental drug overdose, with opioids and benzodiazepines causing him to stop breathing.
How did America get to the point of losing 64,000 Americans to drug overdoses in one year? We’ve traveled a long road to get to this point and in truth, most people haven’t even noticed the journey.
Solving the Opioid Crisis: What Has to Happen to Return Prescription Control to the Right Hands? Part III
Let’s take a look at an ideal world—a world where drugs are only given when they are truly needed to improve health, where there is no undue or skewed influence causing patients to ask for specific types of medication, where doctors use nothing but an honest education to make their choices. What might have to happen to take us in the direction of this ideal world?
When doctors prescribe any drug, it should only be done to improve a patient’s health, right? Over the last few decades, prescribing practices have begun to be influenced too heavily by the wrong parties. Millions of Americans have suffered as a result.
Most Americans know we’re in the midst of a deadly opioid epidemic. But few realize that control of the rate and volume of prescribing addictive painkillers has moved into the wrong hands. Get educated now on this vital topic.
It might seem like every drug likely to be abused by the addicted is kept under lock and key to protect the public. Gabapentin seems to be an exception.
A panel of experts for the FDA rejected the sale of a new extended-release form of oxycodone that dyes the mouth or nose blue when it is abused. Is a blue dye a good method of deterring drug abuse?
Most parents are familiar with the tendency of youth to start using alcohol or marijuana. It’s a good bet, however, that few are ready to think of their teenaged child abusing Xanax, the anti-anxiety drug, especially considering how dangerous this drug is.
A few weeks ago, this blog featured an article on the lawsuits being filed against major pharmaceutical companies such as Purdue Pharma, Endo International, Teva Pharmaceutical Industries, Depomed, Janssen/Johnson & Johnson and others. In the following weeks, even more states, counties and cities have initiated legal action against these companies and others who manufacture, market or distribute these addictive pills.
A new analysis of prescribing patterns for opioid painkillers revealed that three-quarters of these pills go to just 10% of patients. Might a careful analysis of the needs of this small group help curb overprescribing?